Presidential order moves to reschedule marijuana

on
Categories: education

President Trump's Marijuana Rescheduling Executive Order What It Really Means for DOT & Federal Drug Testing

On December 18, 2025, President Donald Trump signed an Executive Order aimed at expediting the federal process to reschedule marijuana to Schedule III and expanding research on medical marijuana and cannabidiol (CBD).

The announcement immediately triggered confusion, particularly in DOT-regulated and federally regulated safety-sensitive industries where drug testing is mandatory and public safety is paramount.

Below is a clear, compliance-first breakdown of what changes, what does not, and where the real risks and misconceptions exist.


What the Executive Order Does (and Does Not) Do

What it does

  • Directs the Attorney General to expedite completion of the marijuana rescheduling process to Schedule III.
  • Encourages federal agencies to remove barriers to marijuana and cannabinoid research, including medical marijuana and CBD.
  • Acknowledges the existing DEA rulemaking process, including the proposed rule issued in May 2024.

What it does not do

  • Rescheduling is not federal legalization.
  • Schedule III substances remain controlled and regulated under federal law.
  • The Order does not override existing DOT or federal safety-sensitive testing rules.

The Quote That Nails the Real Compliance Concern

"This executive order will need much clarification as it relates to the process of rescheduling marijuana, and most importantly there must be a clear determination that DOT, HHS and federally regulated safety-sensitive positions will not be prohibited from continuing to test for marijuana. When implementing this executive order the focus must also be on public safety."

James A. Greer
ADT President & Past Chairman, National Drug & Alcohol Screening Association

This statement captures the core issue: public safety, regulatory authority, and drug testing panel requirements.


DOT Drug Testing: What Happens Right Now

For DOT-regulated employers, operations remain business as usual.

  • DOT testing is governed by 49 CFR Part 40, which explicitly includes marijuana.
  • DOT guidance has consistently stated that state marijuana laws do not override federal testing requirements.
  • Following the Executive Order, DOT leadership reaffirmed that marijuana use remains prohibited for safety-sensitive employees.

Bottom line: As of right now, Schedule III does not mean marijuana is allowed for drivers, pilots, or operators.


The Real Complication: HHS Mandatory Guidelines

DOT testing programs must align with the HHS Mandatory Guidelines, which establish the scientific and technical standards for laboratory testing.

If marijuana is rescheduled, questions may arise regarding how Schedule III substances are treated under existing HHS testing frameworks.

This is why careful clarification is essential, so DOT and federally regulated safety-sensitive programs are not unintentionally prevented from continuing marijuana testing.


Federal Employee Drug Testing Programs

Federal workplace drug testing programs rely on HHS and SAMHSA Mandatory Guidelines. The Executive Order accelerates research and rescheduling, not immediate testing changes.

  • Policies do not automatically change due to scheduling updates.
  • Testing panels change through formal guidance and rulemaking.

What to Watch in 2026

  • DEA final rule and effective date
  • HHS or SAMHSA Mandatory Guideline updates
  • DOT or ODAPC formal guidance
  • Congressional or administrative fixes if conflicts arise

Practical Compliance Guidance

DOT-regulated employers

  • Do not change your DOT drug testing panel.
  • Do not accept medical marijuana cards or prescriptions as a basis to cancel a DOT marijuana positive.
  • Communicate clearly: rescheduling is not permission for safety-sensitive employees.

Federal workplaces and contractors

  • Remain aligned with agency authority and applicable Mandatory Guidelines.
  • Avoid preemptive policy changes until formal written guidance is issued.

The Takeaway:
Testing does not change because headlines change. Testing changes when the rules change. Any implementation must ensure that public safety remains the priority.

0